✦ LIBER ✦

Extended-release carbidopa-levodopa in Parkinson's disease

✍ Scribed by Rascol, Olivier

Book ID: 123327343
Publisher: The Lancet
Year: 2013
Tongue: English
Weight: 42 KB
Volume: 12
Category: Article
ISSN: 1474-4465
DOI: 10.1016/S1474-4422(13)70039-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Randomized trial of IPX066, carbidopa/le

Randomized trial of IPX066, carbidopa/levodopa extended release, in early Parkinson's disease

✍ Pahwa, Rajesh; Lyons, Kelly E.; Hauser, Robert A.; Fahn, Stanley; Jankovic, Jose 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 897 KB

Extended-release carbidopa-levodopa (IPX

Extended-release carbidopa-levodopa (IPX066) compared with immediate-release carbidopa-levodopa in patients with Parkinson's disease and motor fluctuations: a phase 3 randomised, double-blind trial

✍ Hauser, Robert A; Hsu, Ann; Kell, Sherron; Espay, Alberto J; Sethi, Kapil; Stacy 📂 Article 📅 2013 🏛 The Lancet 🌐 English ⚖ 233 KB

Levodopa/carbidopa/entacapone in Parkins

Levodopa/carbidopa/entacapone in Parkinson’s disease

✍ Seeberger, Lauren C; Hauser, Robert A 📂 Article 📅 2009 🏛 Expert Reviews 🌐 English ⚖ 894 KB

Levodopa/carbidopa and Parkinson's disea

Levodopa/carbidopa and Parkinson's disease progression

📂 Article 📅 2004 🏛 Adis International Limited (now part of Wolters Kl ⚖ 121 KB

Carbidopa/levodopa pharmacy errors in Pa

Carbidopa/levodopa pharmacy errors in Parkinson's disease

✍ Nasim R. Khadem; Melissa J. Nirenberg 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 958 KB

## Abstract Outpatient pharmacy errors are common, but little is known about their occurrence in Parkinson's disease (PD). We prospectively studied carbidopa/levodopa pharmacy errors in a cohort of PD outpatients. Over 1 year, pharmacy errors occurred in 8/73 (11%) subjects treated with this medica

Carbidopa/levodopa: ‘surprising’ finding

Carbidopa/levodopa: ‘surprising’ finding in Parkinson’s disease

📂 Article 📅 1997 🏛 Adis International Limited (now part of Wolters Kl ⚖ 173 KB